Innoviva INVA
NASDAQ INVA
$21.11 -0.12 (-0.57%)
At close: Sep 29, 2026 · 4:00 PM EDT

Innoviva (INVA) Total Liabilities (2010 - 2026)

Updated

Innoviva's Total Liabilities was $469.47 million in Q2 2026, down 24.1% from $618.75 million a year earlier and down 5.1% from the prior quarter.

Analysis

Innoviva (INVA) Total Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Total Liabilities at Innoviva came in at $462.32 million, down 24.2% from FY2024.

  • Total Liabilities shows a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
  • In earlier years, Total Liabilities was $609.9 million in FY2024 (+7.3%), $568.55 million in FY2023 (-14.6%), $665.71 million in FY2022 (+66.2%) and $400.46 million in FY2021 (+2.2%).
  • Quarterly Total Liabilities has moved between $395.43 million (Q3 2021) and $665.71 million (Q4 2022) over five years.
  • Compared with a year earlier, Total Liabilities has declined for four straight quarters, with an average decline of 9.5% over the last seven quarters.
  • The best year-over-year quarter for Total Liabilities over five years was Q4 2022 (growth of 66.2%); the worst was Q3 2025 (a decline of 25.6%).
  • Per Business Quant data, INVA's Total Liabilities in the three quarters before Q2 2026 was $494.93 million (Q1 2026), $462.32 million (Q4 2025) and $419.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Innoviva 1.54 Bn -748.67 Mn 90.62 Mn 469.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 469.47 Mn
Mar 31, 2026 494.93 Mn
Dec 31, 2025 462.32 Mn
Sep 30, 2025 419.16 Mn
Jun 30, 2025 618.75 Mn
Mar 31, 2025 607.49 Mn
Dec 31, 2024 609.90 Mn
Sep 30, 2024 563.07 Mn
Jun 30, 2024 559.40 Mn
Mar 31, 2024 563.93 Mn
Dec 31, 2023 568.55 Mn
Sep 30, 2023 560.61 Mn
Jun 30, 2023 563.15 Mn
Mar 31, 2023 568.28 Mn
Dec 31, 2022 665.71 Mn
Sep 30, 2022 686.34 Mn
Jun 30, 2022 572.18 Mn
Mar 31, 2022 555.26 Mn
Dec 31, 2021 400.46 Mn
Sep 30, 2021 395.43 Mn
API Access

Innoviva Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=INVA&period=max&api_key=YOUR_API_KEY